HLA type-independent method to monitor polyoma BK virus-specific CD4 and CD8 T-cell immunity.
about
BK Virus in Kidney Transplant Recipients: The Influence of Immunosuppression.Definition and characterization of novel HLA-*A02-restricted CD8+ T cell epitopes derived from JCV polyomavirus with clinical relevance.Polyomavirus-associated nephropathy: update on BK virus-specific immunity.Modeling Immune Response to BK Virus Infection and Donor Kidney in Renal Transplant Recipients.Clonotype analysis of cytomegalovirus-specific cytotoxic T lymphocytes.HLA-A2, HLA-B44 and HLA-DR15 are associated with lower risk of BK viremia.BK Polyomavirus and the Transplanted Kidney: Immunopathology and Therapeutic Approaches.BK polyomavirus infection and nephropathy: the virus-immune system interplay.Tissue-resident T cells, in situ immunity and transplantation.BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies.Antigen-Specificity of T Cell Infiltrates in Biopsies With T Cell-Mediated Rejection and BK Polyomavirus Viremia: Analysis by Next Generation Sequencing.ABO desensitization affects cellular immunity and infection control after renal transplantation.The Loss of BKV-specific Immunity From Pretransplantation to Posttransplantation Identifies Kidney Transplant Recipients at Increased Risk of BKV Replication.Characterization of urinary CD4⁺ and CD8⁺ T cells in kidney transplantation patients with polyomavirus BK infection and allograft rejection.Inflammatory activation and recovering BKV-specific immunity correlate with self-limited BKV replication after renal transplantation.TCR repertoire analysis by next generation sequencing allows complex differential diagnosis of T cell-related pathology.Pathogenesis of BK virus infection after renal transplantation.BK virus-specific immunity kinetics: a predictor of recovery from polyomavirus BK-associated nephropathy.
P2860
Q35099077-9978661B-5CCD-49D3-945B-A49F2FEB0278Q36153492-69B70564-0B91-46B4-94FB-E237943E0D29Q36492414-68667C91-0811-4185-A79C-6F653D4E2D6DQ36619243-E39B574E-6379-4949-A9E0-384932363142Q37086635-F811779A-2F14-4C8E-A62E-C4F25319165AQ37349698-11F99D4C-AA60-458E-AA7F-8EEAA70848B5Q37375153-49DFA4FC-DFD2-4EBD-9405-487FFFD619FFQ37879442-F2881E82-80BC-4376-85B6-E65C72C9BC4BQ38187175-E970E3A8-C264-49E1-9CAD-823B2C762F63Q39180715-F4ABD2A9-ABF2-4F3E-BF97-D456CFE98291Q40484001-310032A8-4F7C-4A36-BC9E-F79A085C2676Q40879749-E3AAD3FB-8FAD-472E-84DE-81EB08F624F1Q41385328-72352F7C-4736-4FEE-9369-3724C1325E20Q42201895-D83DA847-1C96-41E9-880A-F74D05F467BDQ42252894-7D069665-F2EE-4BCF-A31F-2CC656E06BA7Q42270935-9A792E47-CA1C-440D-AB36-C1CF913A07D2Q44772924-9DDE6038-173E-4B08-B934-3FEDD93B71E3Q45364259-420AB21D-6147-4B27-876B-C38DE09B1081
P2860
HLA type-independent method to monitor polyoma BK virus-specific CD4 and CD8 T-cell immunity.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
HLA type-independent method to ...... c CD4 and CD8 T-cell immunity.
@en
type
label
HLA type-independent method to ...... c CD4 and CD8 T-cell immunity.
@en
prefLabel
HLA type-independent method to ...... c CD4 and CD8 T-cell immunity.
@en
P2093
P2860
P1476
HLA type-independent method to ...... c CD4 and CD8 T-cell immunity.
@en
P2093
Brestrich G
Engelmann E
Rosenberger C
Tillmann H
P2860
P304
P356
10.1111/J.1600-6143.2005.01221.X
P407
P577
2006-03-01T00:00:00Z